Henry Schein stock performance snapshot

Henry Schein (HSIC) stock has drawn investor attention after recent share price moves, with the company reporting positive total returns over the past year and across multi year periods, alongside reported revenue and net income growth.

At the latest share price of US$88.52, Henry Schein has given investors a 16.9% share price return over the past 90 days and a 29.4% total shareholder return over the past year. This suggests momentum has been building recently after a softer week of trading.

Compare Henry Schein's recent momentum with a curated group of health care peers by reviewing the list of solid balance sheet and fundamentals (53 results) that may also be catching investors' attention.

After a 29.4% total return over the past year and increases in revenue and net income, some investors may see Henry Schein as already priced for success. Others may want to evaluate whether the current valuation still suggests additional potential upside.

Most Popular Narrative: 9.3% Undervalued

Based on the most followed narrative, Henry Schein's fair value of $97.56 sits above the latest close at $88.52, which frames the stock as modestly undervalued using a 7.36% discount rate and analyst expectations for future earnings and margins.

The company is experiencing strong growth in high-margin businesses such as Specialty Products, Technology, and private-label offerings, and expects over 50% of non-GAAP operating income to come from these segments, supporting structurally higher gross margins and likely driving earnings expansion. Investments in digital workflow, AI solutions, and integrated cloud-based practice management platforms are accelerating recurring SaaS revenues and client retention, positioning Henry Schein to benefit from the ongoing digital transformation of healthcare, which should support both revenue growth and improved margins.

Read the complete narrative.

Want to see what sits behind that earnings story? The narrative hinges on measured revenue growth, firmer margins, and a future earnings multiple that differs from today.

In simple terms, this popular Henry Schein narrative ties a higher fair value to gradually improving profitability, moderate revenue expansion and a lower P/E assumption in later years compared with today. It also builds in expectations for earnings to rise over time while applying a specific discount rate to translate those future cash flows and profits back into today's dollars. The end result is a fair value estimate that is above the current share price but still anchored in quantified margin and growth assumptions rather than very aggressive forecasts.